CD19 and neoplasm: We further found that LSD1 shRNA anti-CD19 CAR-T cells had comparable levels of TNF-α secretion to RNAU6 anti-CD19 CAR-T cells (Figure 4D), but secreted more IFN-γ, which is capable of indirectly killing tumor cells and affecting immune regulation.